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Abstract
Background: Patients with acute respiratory failure are at risk of deterioration during prehospital transport. Ventilatory
support with continuous positive airway pressure (CPAP) can be initiated in the prehospital setting. The objective of the
study is to evaluate adherence to treatment and effectiveness of CPAP as an addition to standard care.
Methods: In North Denmark Region, patients with acute respiratory failure, whom paramedics assessed as suffering
from acute cardiopulmonary oedema, acute exacerbation of chronic obstructive pulmonary disease or asthma were
treated with CPAP using 100 % O2 from 1 March 2014 to 3 May 2015. Adherence to treatment was evaluated by
number of adverse events and discontinuation of treatment. Intensive care admissions and mortality were reported in
this cohort. Effectiveness was evaluated by changes in peripheral oxygen saturation (SpO2) and respiratory rate during
transport and compared to a historical control (non-CPAP) group treated with standard care only. Values were
compared by hypothesis testing and linear modelling of SpO2 on arrival at scene and ΔSpO2 stratified according to
treatment group.
Results: In fourteen months, 171 patients were treated with CPAP (mean treatment time 35 ± 18 min). Adverse events
were reported in 15 patients (9 %), hereof six discontinued CPAP due to hypotension, nausea or worsening dyspnoea.
One serious adverse event was reported, a suspected pneumothorax treated adequately by an anaesthesiologist called
from a mobile emergency care unit. Among CPAP patients, 45 (27 %) were admitted to an intensive care unit and 24
(14 %) died before hospital discharge. The non-CPAP group consisted of 739 patients. From arrival at scene to arrival at
hospital, CPAP patients had a larger increase in SpO2 than non-CPAP patients (87 to 96 % versus 92 to 96 %, p < 0.01)
and a larger decrease in respiratory rate (32 to 25 versus 28 to 24 breaths/min, p < 0.01). In a linear model, CPAP was
superior to non-CPAP in patients with initial SpO2≤90 % (p < 0.05). One CPAP patient (0.6 %) and eight non-CPAP
patients (1.1 %) were intubated in the prehospital setting.
Discussion: The study design reflects the daily prehospital working environment including long transport timesand
paramedics educated in treating symptoms of acute respiratory failure, rather than treating one specific diagnosis. The
study population was included consecutively and few patients were lost to follow-up. However, the study was too
small to allow assessment of any effect of prehospital CPAP on mortality, nor could the effectiveness in specific disease
conditions be examined.
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Conclusions: In an emergency medical service including physician backup, adherence to CPAP treatment administered
by paramedics was high and treatment was effective in patients with acute respiratory failure.
Keywords: Noninvasive ventilation, Continuous positive airway pressure, CPAP, Dyspnea, Respiratory insufficiency,
Prehospital, Emergency medical services, Paramedic
Background
Acute respiratory failure is one of the major causes of
emergency department admission as reflected by the fact
that 7.3 % of calls to the Danish emergency medical
communication centres (EMCCs) have “difficulty in breath-
ing” as the main symptom [1, 2]. Common causes of non-
traumatic breathing difficulties include acute cardiopul-
monary oedema, lower respiratory tract infections and
acute exacerbation of chronic obstructive pulmonary
disease (COPD) or asthma, which in severe cases may
require non-invasive positive pressure ventilation or
endotracheal intubation and mechanical ventilation. Non-
invasive positive pressure ventilation administered in hos-
pital reduces mortality in patients suffering from acute
cardiopulmonary oedema or acute exacerbations of
chronic obstructive pulmonary disease, while its effect in
patients with acute exacerbations of asthma is uncertain
[3–7]. Patients with acute respiratory failure have a risk of
further deterioration during transport to hospital by emer-
gency medical services (EMS). To prevent situations of
such deterioration, prehospital initiation of continuous
positive airway pressure (CPAP) has become available.
CPAP is administered to patients with spontaneous
breathing through a non-invasive facemask with a positive
airway pressure applied during the entire respiratory cycle
and it has been shown that prehospital CPAP reduces dys-
pnoea and respiratory rate when compared to standard
medical therapy alone [8, 9]. In previous studies of pa-
tients treated with CPAP in the prehospital setting,
reporting of adverse events have included either none
at all, mask intolerance or minor complications such as
hypotension, nausea or vomiting [9–17]. In three of four
randomised controlled trials in prehospital settings,
standard care plus CPAP reduced intubation rate com-
pared to standard care alone [9, 13, 14, 18]. There have
been conflicting results in recent systematic reviews in-
cluding both randomised and observational studies re-
garding the effectiveness of prehospital CPAP on
mortality in patients with acute respiratory failure [19–
21]. Original research studies of CPAP in Nordic EMS
systems are sparse; in a Finnish observational study from
2003, use of prehospital CPAP administered by physicians
to patients with presumed acute severe pulmonary
oedema improved oxygen saturation, respiratory rate,
heart rate and systolic blood pressure [15]. In 2014, the
EMS organisation in North Denmark Region decided to
let paramedics administer CPAP to patients with non-
traumatic acute respiratory failure. Introduction of pre-
hospital CPAP was preceded by educational training in-
cluding preparation of a clinical guideline. The aim of this
study is to evaluate 1) adherence to prehospital CPAP
treatment in patients with acute respiratory failure and 2)




The present study was performed in two steps; firstly, a
prospective study of adherence to prehospital CPAP
treatment in patients with acute respiratory failure, ad-
ministered in addition to standard care (subsequently
denoted “CPAP group”). Secondly, in an uncontrolled
before and after study, measures of effectiveness were
compared to a historical “non-CPAP” group of patients
with symptoms of acute respiratory failure in the same
geographical area, identified from a database of prehospital
medical records. The primary objective was to evaluate
adherence to prehospital CPAP treatment assessed by inci-
dence of adverse events and discontinuation of CPAP treat-
ment. The secondary objective was to evaluate effectiveness
of prehospital CPAP in a post-hoc analysis, assessed by
changes in peripheral capillary oxygen saturation (SpO2)
and in respiratory rate upon treatment.
Setting
The regional EMS served 583,471 inhabitants in mixed
rural and urban areas (7,933 km2) [22]. The EMS was
structured as a three-tier system with 36 primary ambu-
lances, five paramedic vehicles stationed in the rural areas
and 24-h operative mobile emergency care units (MECUs)
staffed by anaesthesiologists in two cities 54 km apart. On
a daily basis, 130–150 patients were transported by the
EMS to one of the three emergency departments in the re-
gion. Nurses operated the regional emergency medical
communication centre by use of a Criteria Based Dispatch
system, The Danish Index of Emergency Care [23]. Either
the EMCC nurse or the EMS personnel on scene could re-
quest assistance from a MECU. Prior to the introduction
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of CPAP, paramedic supervisors completed a four-hour
educational course on CPAP treatment conducted by an
anaesthesiologist and a fellow doctor. The supervisors
subsequently trained all paramedic squads for four
hours. Additionally, comprehensive educational book-
lets on respiratory pathophysiology, indications, contra-
indications and practical handling were distributed to all
paramedics including an overview action card. Whenever
an EMCC nurse categorized a patient’s complaint as “diffi-
culty in breathing”, one of the five paramedic vehicles
equipped with disposable CPAP equipment was dispatched
along with a primary ambulance. All EMS transport events
were entered into a regional database, amPHITM, which in-
cluded registrations of the patient’s respiratory status ob-
served upon EMS arrival, of treatments administered, and
of clinical observations and vital signs obtained during
transport.
Participants
CPAP patients were included during the first 14 months
after introduction of prehospital CPAP: 1 March 2014 to
3 May 2015. Selection criteria were all of the following
three: 1) Patient age ≥18 years, 2) categorized by the
EMCC nurse as having “difficulty in breathing” by use of
The Danish Index of Emergency Care and 3) patient
assessed by paramedics as suffering from acute exacer-
bation of COPD, asthma or acute cardiopulmonary
oedema and treated with prehospital CPAP. Contrain-
dications for initiation of CPAP treatment and reasons
for discontinuing CPAP were as follows: Nausea or
vomiting, reduced level of consciousness, respiratory
fatigue, suspected pneumothorax on auscultation,
hypotension (systolic blood pressure <90 mmHg), cra-
nial or facial trauma, suspected stroke, foreign object in
the airways, penetrating chest trauma, massive bleeding
and epiglottitis.
In order to have a similar comparison group of adult
patients with acute respiratory failure in the uncontrolled
before and after study of effectiveness, we included non-
CPAP patients from the regional EMS database, amPHITM
from the previous 14 months prior to introduction of
CPAP: 1 January 2013 to 28 February 2014. Non-CPAP se-
lection criteria were all of the following three: 1) Patient
age ≥18 years, 2) patient assessed by the arriving EMS
personnel as having severe difficulty in breathing and 3)
treated by the EMS with standard prehospital care which
included high flow oxygen through a non-rebreathing
facemask plus beta agonist and/or diuretics. In both study
groups, pharmacological treatment was in some cases ad-
ministered before arrival of the EMS, e.g. by the general
practitioner who had called the EMCC. In both the
CPAP and non-CPAP study groups, patients were in-
cluded consecutively, including patients with repeated
EMS transports during the intervention and control
study periods.
Standard prehospital care and intervention
Standard prehospital care for acute respiratory failure
consisted of proper positioning of the patient, high flow
oxygen administered by Bag-Valve-Mask ventilation (with
100 % oxygen at a flow of 6–12 L/min) and, depending on
the presumed aetiology, salbutamol inhalation, intraven-
ous furosemide, sublingual nitroglycerine spray and/or
intravenous fentanyl. The MECU physician could be con-
sulted by telephone and be called to the scene in case
non-invasive ventilation was insufficient or in case of
acute deterioration to secure optimal treatment including
endotracheal intubation. In the CPAP study period, para-
medics were instructed to administer CPAP immediately
as an additional treatment to the standard care. The Flow-
Safe II EZ® CPAP System (©Mercury Medical®, Clearwater,
Florida, USA (CE 0086)) provided high flow oxygen on a
fixed level of 100 % and adjustable CPAP/PEEP in the
range 0–13 cm H2O [24]. An integral nebulizer allowed
administration of medications without disrupting the posi-
tive pressure applied. CPAP treatment was continued until
arrival at hospital if no adverse events occurred or contra-
indications arose.
Variables and data collection
Prospective data collection included systematic recording
of: Indication of CPAP treatment, the level of pressure
applied, duration of CPAP treatment and any preterm
discontinuation of CPAP, any adverse events, and any
technical issues on a dedicated registration form. SpO2,
systolic and diastolic blood pressures were monitored
continuously by a LIFEPAK® 12-defibrillator/monitor
(©Physio-Control, Inc., Redmond, Washington, USA).
The prehospital database amPHITM provided information
on demographics, paramedic assessment of the patient’s
presumed cause of acute respiratory failure, pharmaco-
logical treatment, respiratory rate, endotracheal intubation,
and transport times. For CPAP patients, number of days in
hospital, intensive care unit (ICU) admission, in-hospital
treatment with CPAP, non-invasive ventilation (NIV) or
mechanical ventilation and mortality were collected from
medical records via the regional Patient Administrative Sys-
tem. In the prospective study, the primary outcome mea-
sures were incidence of adverse events and discontinuation
of CPAP treatment and secondary outcome measures in-
cluded number of days in hospital, admissions to an ICU
and in-hospital and 30 day mortality in CPAP patients. In
the uncontrolled before and after study, changes in SpO2
and in respiratory rate measured upon arrival at scene and
upon hospital arrival were primary outcome measures of
effectiveness.
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Statistical methods
As the primary objective was adherence to an additional
treatment, no power calculations were done prior to the
study. Data was entered in EpiData Version 3.1. Statistics
were calculated using “R” version 3.2.0. Descriptive data
are presented as mean (± standard deviation (SD)) or
median (interquartile range (IQR)). Vital signs were
compared by either two-sample t test or Mann-Whitney
test according to the distribution of data and results pre-
sented with 95 % confidence intervals [95 % CI]. Propor-
tions were compared by chi-square test or Fisher’s exact
test as appropriate. The association between SpO2 on ar-
rival at scene and ΔSpO2 was modelled by linear regres-
sion (Generalized Linear Models (package glm)) with
adjustment for sex and age and stratified according to
CPAP or non-CPAP group. Patients were categorized ac-
cording to initial SpO2 and recorded values ≤70 % were
excluded from the linear model, as LIFEPAK12 did not
provide precise measures of SpO2 below this limit, ac-
cording to the manufacturer [25]. Linearity of the associ-
ation between initial SpO2 value and ΔSpO2 were visually
assessed and accepted, as was the normal distribution of
residuals. The ggplot2 package (smoothing method
LOESS) was used for graphical presentation. Two-tailed
p-values below 0.05 were considered significant.
Ethical approval
The Danish Data Protection Agency approved the study
(record no. 2008-58-0028). According to The North
Denmark Region Committee on Health Research Ethics,
the study did not require ethical approval or collection of
informed consent from the patients. The Danish Health
Authority waived the requirement for patients to consent
to have their medical records accessed by the researchers
(3-3013-999/1/SABN).
Results
Adherence and adverse events related to prehospital
CPAP treatment
Prehospital CPAP administration was adequately regis-
tered in 171 patients in the CPAP study period. Mean
transport time from departure from scene to arrival at
hospital was 27 (±12) min (N = 149, missing data in 22 pa-
tients). Paramedics administered CPAP treatment for ≤20
min in 42 cases, for 21–40 min in 78 cases and for more
than 40 min in 48 cases and mean treatment time was 35
± 18 min (N = 168, missing data in three patients). Adher-
ence to treatment was 88 % (151/171) measured by the
proportion of patients who continued CPAP treatment all
the way to arrival at hospital. Reasons for discontinu-
ation of CPAP treatment included intolerance to the
facemask in eight patients, occurrence of an adverse event
in six patients, prehospital intubation in one patient and
unknown reasons in five patients. Overall, paramedics
reported adverse events in 9 % (15/171) of the CPAP
patients (Table 1).
In addition to the fifteen listed adverse events, five pa-
tients experienced a critical decrease in SpO2 during
prehospital transport: from 92 to 86 %, from 97 to 91 %,
from 87 to 80 %, from 93 to 85 % and from 94 to 71 %,
respectively (N = 158, missing data in 13 patients). The
latter of the cases was a patient with pulmonary sarcoid-
osis, in which SpO2 decreased markedly even before initi-
ation of CPAP and a MECU was called to the scene. The
attending anaesthesiologist suspected a pneumothorax
and performed an ultrasound examination of the lungs.
CPAP was discontinued and the anaesthesiologist per-
formed a needle decompression, which resulted in audible
escape of air from pleura, ease of breathing and immediate
improvement in SpO2 from 71 % to 95 %. As previously
described, discontinuation of CPAP before arrival at
hospital due to an adverse event occurred in this and
Table 1 Adverse events of prehospital CPAP treatment
CPAP (N = 171)
None 156
Hypotensionab 4
Hereof discontinued CPAP: 1
Nausea 3
Hereof discontinued CPAP: 3
Decrease in level of consciousnessc 2
Hereof discontinued CPAP: 0
Worsening dyspnoea 2
Hereof discontinued CPAP: 1
Suspected pneumothorax 1
Hereof discontinued CPAP: 1
Tachycardia 1
Coughing mucus 1
Dry nose and/or mouth 1
No missing data
CPAP continuous positive airway pressure
aSystolic blood pressure ≤90 mmHg
bNone of the 4 cases were below 80 mmHg
cGlasgow Coma Scale from 15 to 14
Table 2 In-hospital outcomes in CPAP treated patients
CPAP (N = 168)
Days in hospital, median (IQR) 5.5 (3.0–9.0)
Admitted to ICU, N (%) 45 (27 %)
Mortality
In-hospital, all patients, N (%) 24 (14 %)
In-hospital, ICU patients, N (%) 11 (24 %)
30 daysa, N (%) 36 (24 %)
No missing data
CPAP continuous positive airway pressure, ICU intensive care unit,
IQR interquartile range
aBased on first time events only (N = 153)
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five more patients; three due to nausea, one due to
hypotension and one due to worsening dyspnoea. The
latter patient developed shallow breathing during trans-
port, CPAP treatment was discontinued and replaced by
Bag-Valve-Mask ventilation and the breathing pattern was
normalised.
In-hospital outcomes in CPAP treated patients
During hospital stay, 64 % (107/168) of patients in the
CPAP group received no in-hospital ventilation support
in the form of CPAP, NIV and/or mechanical ventilation.
Twenty-seven percent of the patients (45/168) in the
CPAP group were transferred to an ICU. Overall, in-
hospital mortality was 14 % (24/168). Among ICU admitted
patients, in-hospital mortality was 24 % (11/45) (Table 2).
The most frequent diagnoses among patients who died
in hospital were acute exacerbation of COPD, lower
airway tract infections and sepsis.
Patient characteristics in CPAP versus non-CPAP groups
in the prehospital setting
The CPAP group consisted of 171 patients and 739 pa-
tients met the criteria for inclusion in the non-CPAP
group (Fig. 1). The proportion of males was higher in
the CPAP group, while the distribution of age was
similar (Table 3).
Presumed causes of acute respiratory failure assessed
by the EMS varied between the two study groups; acute
Fig. 1 Study population flowchart
Table 3 Patient demographics and presumed cause of ARF







Male, % 60 % 50%a 0.02
Age, years, median (IQR) 73 (64–80) 74 (64–81)b 0.99
Presumed cause of ARF
Acute cardiopulmonary
oedema
18.1 % 13.3 % 0.10c
Asthma, acute exacerbation 5.3 % 7.3 % 0.34c
COPD, acute exacerbation 57.3 % 45.5 % 0.01c
Combined COPD and acute
cardiopulmonary oedema
2.3 % 3.4 % 0.63d
Combined COPD and asthma 1.2 % 4.2 % 0.07d
Other 12.9 % 14.2 % 0.65c
Unknown or not reported 2.9 % 12.2 % <0.01d
No missing data unless otherwise stated
ARF acute respiratory failure, COPD chronic obstructive pulmonary disease,




cCalculated by chi-square test
dCalculated by Fisher’s exact test
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exacerbation of COPD and acute cardiopulmonary
oedema were more frequently reported in the CPAP
group whereas unknown causes were more frequent in
the non-CPAP group (Table 3). Amongst “other” causes
were e.g. unspecified dyspnoea, angina pectoris, allergic
reactions and unconsciousness. On arrival at scene, pa-
tients in the CPAP group had a lower SpO2 (87 % versus
92 %) and a higher respiratory rate (32 breaths/min ver-
sus 28 breaths/min) than non-CPAP patients, while
blood pressures were similar (Table 4).
Effectiveness of prehospital CPAP versus non-CPAP
treatment
During transport, CPAP patients had a larger median
increase in SpO2 compared to non-CPAP patients (8
percentage points versus 2 percentage points, p < 0.01,
95 % CI [4, 7]) (CPAP group: N = 158, non-CPAP group:
N = 712). Increases in SpO2 were higher the lower the ini-
tial SpO2 value as demonstrated in Fig. 2, and this pattern
was unaffected by adjustment for sex and age (Table 5).
In this linear model, initial SpO2 ≤70 % were excluded
due to imprecision of the measuring device; 23 in the
CPAP group and 60 in the non-CPAP group. The de-
crease in respiratory rate was larger among CPAP pa-
tients than among non-CPAP patients; a median
decrease of 8 breaths/min versus 2 breaths/min, respect-
ively (p < 0.01, 95 % CI [−5, −3]) (CPAP group: N = 162,
non-CPAP group: N = 539). On arrival at hospital, SpO2
(CPAP 96 % versus non-CPAP 96 %) and respiratory rate
(CPAP 25 breaths/min versus non-CPAP 24 breaths/min)
Table 4 Vital signs recorded upon arrival at scene and arrival at
hospital
CPAP Non-CPAP ρ-value
Status on arrival at scene
SpO2, % 87 (77–94) 92 (85–97) <0.01
(N = 159) (N = 723)
Respiratory rate, breaths/min 32 (28–38) 28 (24–32) <0.01
(N = 163) (N = 692)
Systolic blood pressurea, mmHg 157 (± 34) 155 (± 33) 0.51
(N = 159) (N = 704)
Diastolic blood pressurea, mmHg 92 (± 24) 93 (± 24) 0.93
(N = 145) (N = 704)
Status on arrival at hospital
SpO2, % 96 (94–99) 96 (91–98) 0.02
(N = 168) (N = 715)
Respiratory rate, breaths/min 25 (21–30) 24 (21–30) 0.67
(N = 163) (N = 550)
Systolic blood pressurea, mmHg 140 (± 25) 142 (± 30) 0.25
(N = 156) (N = 679)
Diastolic blood pressurea, mmHg 85 (± 19) 86 (± 24) 0.59
(N = 145) (N = 676)
Data presented as median (IQR) unless otherwise stated
CPAP continuous positive airway pressure, IQR interquartile range, SD standard
deviation,
SpO2 peripheral capillary oxygen saturation
amean (± SD)
Fig. 2 Changes in SpO2 from arrival at scene to arrival at hospital as a function of initial SpO2 value and according to study group. Grey areas
represent 95 % confidence limits. Number of points: 30. CPAP group: N = 136. Non-CPAP group: N = 663
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did not differ between the study groups (Table 4). Lowest
respiratory rate after CPAP treatment was 11 breaths per
minute.
Concurrent prehospital management in CPAP versus
non-CPAP groups
Use of concurrent pharmacological treatments varied
between the two study groups (Table 6); a larger propor-
tion of patients in the CPAP group received furosemide,
fentanyl and nitroglycerine than in the non-CPAP group,
while a smaller proportion received salbutamol. One pa-
tient (0.6 %) in the CPAP group and eight patients
(1.1 %) in the non-CPAP group were intubated before
arrival at hospital (missing data in 0 patients).
Discussion
In this prospective study of prehospital CPAP to patients
with acute respiratory failure, adherence to treatment
was high as 88 % of all patients were treated with CPAP
during the entire transport from scene to hospital. Ad-
verse events were minor, except for one serious event, a
pneumothorax. CPAP as a supplement to standard care
was associated with larger improvements in SpO2 and
respiratory rate compared to a historical cohort of pa-
tients treated with standard care alone.
Adherence to treatment
CPAP is used in-hospital to treat patients with acute car-
diopulmonary oedema, but is not recommended for
acute exacerbations of COPD or asthma. Previous
studies of prehospital CPAP treatment with cohorts of
60–149 patients with acute cardiogenic pulmonary
oedema have not reported any serious adverse events
[9–15]. Williams et al. reported that only 41 % of pa-
tients, who were coded as acute pulmonary oedema by a
paramedic had this particular emergency department
discharge diagnosis [26]. Accordingly, a CPAP protocol
restricted to patients with presumed acute cardiopulmo-
nary oedema is likely to be started even if the patient is
suffering from acute respiratory failure from a different
aetiology. In our study, we investigated if CPAP was safe
to use in prehospital patients with acute respiratory fail-
ure from either acute cardiopulmonary oedema, acute
exacerbation of COPD or asthma. Prehospital data col-
lection including potential adverse events was planned
prospectively, which made paramedics consistently as-
sess and report any adverse events, minor as well as ser-
ious. Potential serious adverse events of prehospital
CPAP treatment include apnoea, therapy failure in car-
diogenic shock for example due to acute myocardial in-
farction and risk of either resulting in a pneumothorax
or worsening an existing one [27, 28]. In the present
study, no patients developed a systolic blood pressure
<80 mmHg as an indication of impaired cardiac func-
tion. Likewise, no patients developed apnoea, yet two pa-
tients experienced worsening dyspnoea upon treatment
with CPAP. We consider it likely, that the one serious
adverse event of a pneumothorax in our cohort was due
to or worsened by CPAP. A similar adverse event has
been reported in a case series study, where one patient
had failed prehospital CPAP and a pneumothorax was
discovered following intubation and mechanical ventila-
tion in the emergency department [29]. In five cases in
our study, SpO2 actually decreased upon CPAP treat-
ment, indicating a worsening of the condition. All ad-
verse events of CPAP treatment in the present study was
managed and treated adequately in the prehospital set-
ting with shift to standard care or assistance from a
physician staffed MECU. These cases illustrate how
CPAP may be administered inadvertently to a patient,
whose final diagnosis is different than presumed by para-
medics. Our results demonstrate, that CPAP treatment
is feasible in a prehospital setting, where time is limited
Table 5 Changes in SpO2 during transport to hospital
SpO2 on arrival at scene
71–80 % 81–90 % >90 %
CPAP Non-CPAP CPAP Non-CPAP CPAP Non-CPAP
Unadjusted +16.2* +9.4* +9.8* +5.9* +1.5 0
Adjusted for sex and age +16.5* +9.2* +9.9* +6.0* +1.6 −0.1
Changes in SpO2 from arrival at scene to arrival at hospital according to initial SpO2 value and study group
CPAP group: N = 136. Non-CPAP group: N = 663
CPAP continuous positive airway pressure, SpO2 peripheral capillary oxygen saturation
*p < 0.05
Table 6 Prehospital pharmacological treatment
CPAP (N = 171) Non-CPAP (N = 739) ρ-value
Intravenous
Furosemide, N (%) 50 (29 %) 152 (21 %) 0.01
Fentanyl, N (%) 29 (17 %) 88 (12 %) 0.08
Sublingual spray
Nitroglycerine, N (%) 46 (27 %) 140 (19 %) 0.02
Inhalation
Salbutamol, N (%) 108 (63 %) 589 (80 %) <0.01
No missing data
CPAP continuous positive airway pressure
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and differentiation between cardiogenic, pulmonary and
other aetiologies of acute respiratory failure is difficult.
The results also emphasize the need for caution and fre-
quent reassessment of the patient’s SpO2 and clinical
condition during CPAP treatment and call for physician
assistance to manage any complications.
Effectiveness
The present study was too small to allow assessment of
any effect of prehospital CPAP on mortality, nor could
the effectiveness of CPAP treatment in specific disease
conditions be examined. The study design, however, re-
flects the daily prehospital working environment, in
which EMS personnel generally do not give specific
diagnoses before considering how to treat the patient, and
on average respiratory parameters improved in our study
population. As expected from the oxygen-haemoglobin
dissociation curve, the effectiveness of treatment on SpO2
reported in this study diminished with increasing initial
SpO2 values (>90 %), which should be taken into consider-
ation when planning future studies. Measures of gas ex-
change would have been valuable to the study. Originally,
registration of end-tidal CO2 was mandatory; however, the
variable was dropped as the patients’ CO2 were diluted
from the high gas flow in the CPAP system. Development
of respiratory acidosis as an outcome measure was not ap-
plicable in this study as the patients’ arterial gas samples
were not routinely entered in to the patients’ electronic
medical records. In future studies, arterial gas sampling
will be a useful outcome measure. Addition of prehospital
CPAP to medical therapy improved SpO2 and respiratory
rate in patients with acute respiratory failure in several ob-
servational studies [16, 27, 28]. Comparison of standard
medical therapy plus CPAP to standard medical therapy
alone has shown, that CPAP is superior when using SpO2
or respiratory rate as outcome measures of effectiveness in
patients with acute cardiopulmonary oedema or acute re-
spiratory failure [10, 12, 17]. Two recent studies of prehos-
pital patients with respiratory distress, conducted in North
American urban settings, did not find any benefit of CPAP
when comparing groups before and after implementation
[30, 31]. The study protocols aimed at patients with pre-
sumed heart failure, COPD or asthma and the study pa-
tients’ initial oxygen saturation and respiratory rate were
comparable to initial values in this study population.
Transport time from departure from scene to arrival at
emergency department was considerably shorter than in
the present study, only 9.6 min [30]. Distance and trans-
port time to hospital is an important factor when deciding
how to treat patients with acute respiratory failure during
ambulance transport; it is always a balance between time
used to initiate a prehospital treatment and a faster arrival
to definitive treatment at hospital. Our study showed that
CPAP was effective in an EMS system with a mean
treatment time of 35 min, reflecting the relatively long
transport times in the region. In the prehospital setting,
oxygen therapy should be given cautiously; high flow oxy-
gen has been associated with increased mortality com-
pared to titrated oxygen treatment in patients with
presumed acute exacerbation of COPD [32]. In both our
study groups, the high concentration of oxygen may have
removed nitrogen from the alveoli and subsequently in-
duced absorption atelectasis and it may also have led to
hypercapnia in oxygen sensitive COPD patients. We pre-
sume that no patients experienced severe hyperoxaemia
and/or severe hypercapnia in our study, since the two
examples of decrease in level of consciousness were
minor and respiratory rate did not decrease below 11
breaths per minute following CPAP treatment. More-
over, in acute myocardial infarction, prehospital oxygen
therapy has been associated with larger myocardial in-
farct size compared to no oxygen therapy in patients with
acute ST-elevation myocardial infarction and no hypoxia
[33]. Lower fractional oxygen with CPAP improved oxy-
gen saturation and respiratory rate in patients with acute
respiratory failure in previous observational studies [17,
27]. Nonetheless, both our study groups were treated with
100 % oxygen as titrated oxygen treatment was not yet
possible in the region’s ambulances.
Strengths and limitations
Strengths of the present study include a population based
and consecutive sample of 171 patients treated with CPAP
in daily prehospital practice, and few patients were lost to
follow-up. External validity of this observational study is
regarded as high in countries with similar disease patterns
and EMS structures. The study design contains limita-
tions; retrospective data collection from the historical
non-CPAP group, risk of regression to the mean value and
obvious confounding in the form of concurrent pharma-
cological treatment. No changes, apart from addition of
CPAP trough a tight facemask, were made to EMS
treatment for acute respiratory failure across the two
study periods. Nevertheless, concurrent pharmacological
treatments varied between study groups, probably due to
differences in the case mix between the two groups, and
though differences were small, the impact on our results is
unknown. During the CPAP study period, inclusion was
limited to cases, in which a paramedic vehicle was avail-
able and dispatched, causing a selection bias. In the study
design, the individual paramedic both served as treatment
provider and data collector by which observer bias was in-
duced. We cannot estimate the impact of case mix differ-
ences that were not included in the linear model, e.g.
presumed pathology, initial respiratory rate or any bias
resulting from the varying selection criteria of patients in
the two study groups. Due to above mentioned limitations,
the presented results ought to be interpreted as
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exploratory results. As patients with initial SpO2 values
≤70 % were excluded from both treatment groups due
to imprecise measurement, we are not able to conclude
on effectiveness of CPAP in patients with SpO2 values
below this limit.
Conclusions
In a three-tier EMS system including on-call physician
backup, adherence to prehospital CPAP treatment ad-
ministered by paramedics was high in patients with
acute respiratory failure. Few adverse events were re-
ported, including one potentially serious adverse event
averted by a rendezvous physician. Patients treated with
standard care plus CPAP experienced larger increases in
SpO2 and reduced respiratory rate during prehospital
transport compared to a historical cohort of patients
treated with standard care only. The study is useful in
future trial planning and for EMS systems intending to
implement prehospital CPAP. Randomised studies are
required to demonstrate short-term and long-term effects
of prehospital CPAP including effects of low versus high
flow oxygen.
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